MENU

Oramed Pharmaceuticals (ORMP) Ownership - Who owns Oramed Pharmaceuticals?

Profile

Industry
Pharmaceuticals Other
Address
1185 Avenue of the Americas
Phone
+1 844 967-2633
Employees
15
Web
https://www.oramed.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
101.51M
P/E Ratio
4.88
Total Cash
152.74M
Projected Growth
N/A
Total Debt
486K
Revenue
N/A
Risk (Beta)
1.44
Dividend Yield
N/A
Total Cash/Share
3.75
Total Debt/Equity
0.22
Revenue/Share
null USD as % of share price

Fundamentals

ORMP
Capitalization
102M
P/E Ratio
4.88
Risk (Beta)
1.44
Dividend Yield
N/A
Total Cash
153M
Total Cash/Share
3.75
Total Debt
486K
Total Debt/Equity
0.22
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
177M
P/B Ratio
0.57
Cash Flow
N/A
Earnings
0.51
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
488K
Current Ratio
41.06
Current Revenue Per Employee
39647.06
Dividends Per Share - Security
N/A
EBITDA
25.5M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
12.25
Shares Held By Institutions
17.1M
Shares Outstanding - Current
40.8M
Total Liabilities
8.07M
Total Volume MTD
N/A
Value
N/A
Gain YTD
7.792
View a ticker or compare two or three
ORMP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company which engages in pharmaceutical preparations

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1185 Avenue of the Americas
Phone
+1 844 967-2633
Employees
15
Web
https://www.oramed.com